Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Xetra  >  MorphoSys AG    MOR   DE0006632003

MORPHOSYS AG (MOR)

42
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/03/2015 Date
64.87(c) 64.38(c) 65.42(c) 64.3(c) 65.08(c) Last
171 409 135 033 154 908 108 791 83 426 Volume
-4.55% -0.76% +1.62% -1.71% +1.21% Change
More quotes
Financials (€)
Sales 2015 105 M
EBIT 2015 11,9 M
Net income 2015 1,81 M
Finance 2015 262 M
Yield 2015 -
Sales 2016 63,9 M
EBIT 2016 9,46 M
Net income 2016 8,81 M
Finance 2016 275 M
Yield 2016 -
PER 2015 165,26
PER 2016 197,87
EV / Sales 2015 14,0x
EV / Sales 2016 22,7x
Capitalization 1 723 M
More Financials
Company
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications.It operates through the following segments: Partnered Discovery, Proprietary Development, and AbD Serotec.The Partnered Discovery segment involves technologies for the generation of human... 
More about the company
Surperformance© ratings of MorphoSys AG
Trading Rating : Investor Rating :
More Ratings
Latest news on MORPHOSYS AG
06/01 MORPHOSYS : Presents Updated Phase 2 Clinical Results for MOR208 Monotherapy in ..
05/31 MORPHOSYS : Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 ..
05/31 MORPHOSYS : Presents First Safety, Pharmacokinetic and Efficacy Data for MOR202 ..
05/29 MORPHOSYS : to Present at Five Upcoming Conferences
05/22 MORPHOSYS : to Present Data on Proprietary Programs at 20th Congress of the Euro..
05/21 MorphoSys to Present Data on Proprietary Programs at 20th Congress of the Eur..
05/21 MORPHOSYS : to Present Data on Proprietary Programs at 20th Congress of the Euro..
05/13 MORPHOSYS : to Present Data on Proprietary Programs at American Society of Clini..
More news
Sector news : Biotechnology & Medical Research - NEC
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/02 QUINTILES TRANSNATIONAL : and Quest Diagnostics Launch Q2 Solutions
07/01 QUINTILES TRANSNATIONAL : ’ Second Quarter 2015 Earnings Call Scheduled fo..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/05 MorphoSys's (MPSYF) CEO Seth Fischer on Q1 2015 Results - Earnings Call Trans..
04/17 CELGENE : A Pre-Earnings Discussion Based On Recent News
02/26 MorphoSys' (MPSYF) CEO Simon Moroney on Q4 2014 Results - Earnings Call Trans..


Comments 
Advertisement
Chart MORPHOSYS AG
Duration : Period :
MorphoSys AG Technical Analysis Chart | MOR | DE0006632003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions